Factors affecting timeliness in management of head and neck cancer

被引:2
|
作者
Kwok, Matthew Ming Kei [1 ]
Wong, Amy [1 ]
Prasad, Jessica [1 ]
机构
[1] Footscray Hosp, Dept Otolaryngol Head & Neck Surg, Western Hlth, 160 Gordon St, Melbourne, Vic 3011, Australia
关键词
delayed diagnosis; head and neck neoplasms; squamous cell carcinoma of head and neck; surgery; time-to-treatment; SQUAMOUS-CELL CARCINOMA; DELAY; DISPARITIES; QUEENSLAND; DIAGNOSIS; OUTCOMES; PATIENT;
D O I
10.1111/ans.18521
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundTimeliness in the management of patients with head and neck cancer (HNC) can be affected by both patient and non-patient related factors. This study aims to investigate the factors associated with the timeliness of managing HNC. MethodsA retrospective review was conducted on Western Health medical records including all new patients presenting to the Western Health HNC surgical outpatient clinic in the five-year period from first January 2017 to 31st December 2021 with the diagnosis of a HNC. Both patient and non-patient related factors were compared with the duration between a patient's referral to a HNC service and the commencement of their treatment. ResultsTwo hundred and twenty-eight patients were included in this study. The median duration from referral to the commencement of treatment was 48 days. Lack of radiological or pathological investigations prior to referral to a HNC service as well as early staging were found to significantly impact timeliness in management. Socioeconomic factors such as non-English speaking backgrounds, distance from the hospital and lack of social supports were not found to negatively impact timeliness of management. ConclusionThe management of patients with HNC require careful consideration of all patient and non-patient related factors which may affect timeliness in management, particularly investigations performed prior to their referral to a HNC service.
引用
收藏
页码:2388 / 2393
页数:6
相关论文
共 50 条
  • [21] Current Challenges in Head and Neck Cancer Management
    Starzynska, Anna
    Sobocki, Bartosz Kamil
    Alterio, Daniela
    CANCERS, 2022, 14 (02)
  • [22] Management of elderly patients with head and neck cancer
    Ishii, Ryo
    Ohkoshi, Akira
    Kiyota, Naomi
    Matsuura, Kazuto
    Yasuda, Koichi
    Imamura, Yoshinori
    Saito, Yuki
    Homma, Akihiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (04) : 313 - 321
  • [23] Induction Chemotherapy in the Management of Head and Neck Cancer
    Fury, Matthew G.
    Shah, Jatin P.
    JOURNAL OF SURGICAL ONCOLOGY, 2010, 101 (04) : 292 - 298
  • [24] Multidisciplinary Clinic Management of Head and Neck Cancer
    Townsend, Melanie
    Kallogjeri, Dorina
    Scott-Wittenborn, Nicholas
    Gerull, Katherine
    Jansen, Stacy
    Nussenbaum, Brian
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2017, 143 (12) : 1213 - 1219
  • [25] The Management of the Head and Neck Paragangliomas
    Iseri, Mete
    Ila, Kadri
    Koc, Kenan
    Yavuz, Sadan
    Keskin, I. Gurkan
    Aydin, Omer
    TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2012, 32 (05): : 1327 - 1334
  • [26] Modern Radiology in the Management of Head and Neck Cancer
    Burkill, G. J. C.
    Evans, R. M.
    Raman, V. V.
    Connor, S. E. J.
    CLINICAL ONCOLOGY, 2016, 28 (07) : 440 - 450
  • [27] Leveraging Genomics for Head and Neck Cancer Treatment
    Kemmer, J. D.
    Johnson, D. E.
    Grandis, J. R.
    JOURNAL OF DENTAL RESEARCH, 2018, 97 (06) : 603 - 613
  • [28] Is there a "July effect" for head and neck cancer surgery?
    Hennessey, Patrick T.
    Francis, Howard W.
    Gourin, Christine G.
    LARYNGOSCOPE, 2013, 123 (08) : 1889 - 1895
  • [29] Perineural invasion and spread in head and neck cancer
    Johnston, Meredith
    Yu, Eugene
    Kim, John
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (03) : 359 - 371
  • [30] Identifying the risk factors for late-stage head and neck cancer
    Worsham, Maria J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (09) : 1321 - 1325